News

MARINOMED RECEIVES EUR 15M EIB FINANCING

HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing

HEAVY METALS WEIGH ON UNBORN BABIES’ HEALTH

Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019

HOOKIPA Appoints Michael A. Kelly as Independent Director

Marinomed Biotech AG announces result of conversion of convertible bonds

Nordic Life Science Days 2019 – LISA is conference supporter

New research study demonstrates enGenes X-press glycosyltransferase yield advantages

Conversion of CO2 into animal feed

Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate

MARINOMED ANNOUNCES STRONG INVESTOR DEMAND AND EXPECTED OFFER PRICE

THE WINE DETECTIVES: HIGH-PRECISION CHEMICAL FINGERPRINT ALLOWS UNAMBIGUOUS IDENTIFICATION

The impacts of invasive species are often difficult to predict

New treatment approach for leukemia

LISA Shows in 2019

MARINOMED RESUMES OFFER PERIOD OF INITIAL PUBLIC OFFERING ON THE VIENNA STOCK EXCHANGE

Listeria in the feed: A dangerous hygiene problem in fattening pigs

Marinomed: Partnership in China and EIB Financing

Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019

Valneva Announces New $59 Million IXIARO® Supply Contract with US Government